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Objective: Large randomized trials have confirmed a difference in outcome after carotid endarterectomy (CEA) between
men and women. In this review, we aimed to provide an overview of the gender-specific characteristics causing these
perioperative and long-term outcome differences between men and women after CEA.
Methods: A systematic search strategy with the synonyms of ‘gender’ and ‘carotid endarterectomy’ was conducted from
PubMed and EMBASE databases. Only 11 relevant studies specifically discussing gender-specific related characteristics
and their influence on outcome after CEA could be identified.
Results: Due to the limited number of included studies, pooling of findings was impossible, and results are presented in
a descriptive manner. Each included study described only one possible gender-specific factor. Differences in carotid artery
diameter, sex hormones, sensitivity for antiplatelet therapy, plaque morphology, occurrence of microembolic signals, and
restenosis rate have all been suggested as gender-specific characteristics influencing outcome after CEA.
Conclusion: Higher embolic potential in women and relatively stable female plaque morphology are the best-described
factors influencing the difference in outcomes between men and women. However, the overall evidence for outcome
differences by gender-specific characteristics in the literature is limited. (J Vasc Surg 2010;52:1062-71.)Carotid endarterectomy (CEA) combined with best
medical management (BMT) has been proven to be supe-
rior to BMT alone in the management of high-grade ca-
rotid artery stenosis.1-4 The relative risk reduction for
stroke by CEA, however, is determined importantly by
surgical success and perioperative clinical outcome.3 Both
technical factors and patient-related factors have been re-
lated to neurologic adverse outcome after CEA.5-7
Clinical subgroup analyses of relevant trial data have
shown the benefits from CEA for both symptomatic and
asymptomatic carotid stenosis is less inwomen than inmen.8,9
Most articles describing the relation between gender and
perioperative complications of CEA concentrate on 30-day
procedural outcome. In the North American Symptomatic
Carotid Endarterectomy Trial, the odds ratio (OR) for peri-
operative stroke in symptomatic patients was 1.7 for women
relative to men, whereas in an analysis of Asymptomatic Ca-
rotid Atherosclerosis Study data, the relative risk of 30-day
death or stroke was 3.3 for asymptomatic women relative to
men.10,11
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1062Furthermore, the long-term benefit of CEA is reflected
by the rate of restenosis with the majority of reports show-
ing a significantly increased early restenosis rate in women
compared to men.12-16 With the influence of gender on
both short-term and long-term outcomes after CEA being
confirmed in several observational studies,17,18 it seems of
interest to investigate the factors that may cause these gender
differences and to analyze if these etiologic factors can explain
the outcome difference between men and women.
Several factors have been suggested to contribute to the
poorer outcome in women.19-22 (1) Nonmodifiable patient-
related factors such as: presenting symptoms, vessel diameter,
sensitivity for antiplatelet therapy, sex hormones, plaque com-
position, and restenosis rate; (2) modifiable technical factors
such as: shunt use or patch type; and (3) a combination of
patient and technical related factors: the occurrence of
microembolic signals (MES) might translate into a differ-
ence in outcome between men and women. Surprisingly,
analysis of the patient-related nontechnical and nonmodi-
fiable factors specifically has, as far as we know, never been
the subject of a prospective study. Despite this, etiologic
factors function in clinical practice as important criteria in
optimal patient selection for surgery. Therefore, in this
review we aimed to define and summarize the evidence for
gender-specific characteristics causing perioperative and
long-term outcome differences between men and women
after CEA.
METHODS
Search strategy. A systematic literature search of all
studies relating to gender and CEA was conducted on
February 19, 2010 according to the search strategy and
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tional Studies in Epidemiology criteria.23 Studies were
initially identified from PubMed and EMBASE database
using synonyms for “gender” and “carotid endarterec-
tomy.” A flowchart of this search strategy is shown in Fig 1,
resulting in 1056 articles after disregarding the duplicate
articles.
Selection of articles. Two authors (A.H., G.B.) inde-
pendently screened the articles on title/abstract and con-
secutively on full text with the following inclusion and
exclusion criteria. Included articles had to fulfill all the
following 3 inclusion criteria: (1) presenting original data
on outcome of CEA (eg, perioperative risk, restenosis,
plaque morphology); (2) outcome specified for gender;
and (3) analysis of gender-specific outcome, with any factor
of influence being discussed. Studies were excluded match-
ing one of the following criteria: (1) no relation between
gender and outcome presented in the Results section; (2)
non-English written papers; (3) nonhuman data; and (4)
full-text paper unavailable (10 articles). All unavailable full
text articles were excluded for not meeting our inclusion
and exclusion criteria based on title and abstract. Subse-
quently, the reference lists of the selected articles were
checked for missing articles. This resulted in one additional
article focusing on the difference in vessel diameter be-
tween men and women.24
We wish to emphasize that this review did not aim to
describe and summarize the actual outcome differences
Fig 1. Flowchart of the literature search.between men and women after CEA and all their theoret-ically related causes. We purposely focused our search on
studies determining and specifying causal (gender-related)
factors of the reported outcome difference.
In total, 11 full text articles met our inclusion criteria. A
priori we planned analysis for the following subgroups: (1)
vessel size; (2) plaque morphology; (3) antiplatelet sensi-
tivity; (4) influence of sex hormones; (5) microembolic
potential; and (6) restenosis. These subgroups seem valu-
able because they represent the main suggested arguments
in literature for the existing discrepancy in outcome after
CEA between men and women. Other factors with a sug-
gested causative role, but not studied in combination with
CEA (inclusion criteria 1), or only presenting a risk factor
for developing (carotid) atherosclerosis, could not be in-
cluded in our search but are shortly summarized in the
Discussion section of this article.
Statistical analysis. We calculated the risk ratios
(RRs) with accompanying 95% confidence intervals (CIs)
to compare risks between groups. For the comparison of
continuous variables, we computed mean differences with
95% CIs.
RESULTS
Our search resulted in 11 studies (Tables I and II) that
could be used for further analysis. Subdivided in the sub-
groups: (1) vessel size, 1 article24; (2) plaque morphology,
1 article25; (3) antiplatelet sensitivity, no articles; (4) influ-
ence of sex hormones, 1 article26; (5) microembolic poten-
tial, 7 articles27-33; and (6) restenosis, 1 article.34 Originally
we identified multiple studies in our search strategy that
evaluated one of the above topics and gender as a potential
predictor of CEA outcome. However, these articles did not
report on the etiology of this relation and are, therefore, not
the focus of our review. Furthermore, none of the included
studies presented or discussed more than one gender-related
factor simultaneously. No effort was made to pool findings
from the different studies because the selected studies
varied too much in presentation, study population, and
other relevant characteristics. Therefore, results of our anal-
ysis of selected studies are summarized and presented in a
descriptive manner.
Vessel size
In the literature on CEA, most authors assume and
mention relative carotid artery diameter as a factor influenc-
ing operative results.18,32 In our search, one article de-
scribed the impact of duplex ultrasound scan-measured
carotid artery diameter on post-CEA outcome and speci-
fied this for gender.24 This study on 192 symptomatic
patients, however, did not look at perioperative outcome
between men and women, but focused on the relation
between carotid artery diameter and occurrence of resteno-
sis. Before the operation, men generally had a larger diam-
eter of the internal carotid artery (ICA) than women. For
their analysis, the authors used the external rather than the
intraluminal diameter. The median ICA diameter was 5
mm (range, 3-8mm) in the 58 women and 6mm (4-8.5) in
the 131 men. Women underwent patch repair more often
intern
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carotid diameters for men and women were more compa-
rable after surgery. One week after CEA, the median diam-
eter was 5.6 mm (3.2-9.1) in women vs 6 mm (4-8.8) in
men. Although this is a negligible difference, after 2 years,
the restenosis rate in women was 17% vs 9% in men. This
difference, however, was not statistically significant. Patch-
ing was not associated with restenosis whereas 96 patients
of the 103 patients with a Dacron patched artery did not
develop restenosis. As far as we know, no further follow-up
of this patient cohort has been reported and no outcome of
men and women with similar sized vessels was specifically
mentioned.
Plaque morphology
The relationship between plaque morphology, gender,
and outcome was analyzed in one article.25 In this study of
plaques removed from 450 consecutive patients with CEA
(135 women, 315men; 102 were symptomatic women and
246 were symptomatic men), those obtained from women
were more often found to be fibrous and fibroatheroma-
tous than atheromatous. Female plaques contained less fat,
less macrophages, relatively more smooth muscle cells (Ta-
ble III), and consequently were considered less likely to
disrupt.
In a subanalysis, asymptomatic women had an athero-
Table I. Summary of the main findings of included studie
Factor
Vessel diameter
Golledge et al24 Preoperative, women generally had sm
Plaque morphology
Hellings et al25 Women have more stable and less infl
prevalence of stable plaques was fou
Sex hormones
Lane et al26 Perioperative stroke rate in women us
Due to small sample size, this differ
Emboli
Ackerstaff et al27 TCD detected emboli during dissectio
complications after CEA. However,
it was too heterogeneously distribu
Golledge et al28 Preoperative emboli were more comm
were more common in women and
Hayes et al29 A possible explanation for the increase
potential of women. Women develo
postoperative period, which was sta
Horn et al30 A statistically significant association of
phase is documented in univariate a
nonsignificant trend for female sex
Laman et al31 In the postoperative period women ha
earlier cerebrovascular complication
Stork et al32 Three factors associated with the pred
.027); (2) patients not receiving pre
sided endarterectomy.
Verhoeven et al33 The occurrence of MES during woun
Restenosis
Anderson et al34 Measurement of the ICA diameter 12
patients. Moreover, no significant d
restenosed and that remained paten
CEA, Carotid endarterectomy; HRT, hormone replacement therapy; ICA,matous plaque phenotype less often than asymptomaticmen. This difference was noted to be less significant in
symptomatic women (27%) vs symptomatic men (44%).
The authors concluded that (especially asymptomatic)
women with hemodynamically significant ICA stenosis
have more stable plaques than men (Table III).
Besides description of plaque phenotype, plaque pro-
tein was isolated for detecting interleukin (IL)-6, IL-8,
and the presence of matrix metalloproteinases (MMPs).
Women showed lower plaque levels of IL-8, whereas the
activity of IL-6 did not differ between men and women
(Table IV). Protease activity in women was lower; MMP-8
and MMP-9 showed significantly higher values in men.
These protease activity differences were present both in the
asymptomatic and symptomatic subgroup.
Sensitivity for antiplatelets
Our search strategy could not detect any studies that
looked at the relationship of sensitivity for antiplatelet
therapy, gender, and CEA.
Influence of sex hormones
One study investigated the role of sex hormones on
outcome after CEA focusing on the use of estrogen-based
hormone replacement therapy (HRT).26 In this study, 326
patients were operated on by a single surgeon. CEA was
performed for symptomatic stenosis (55 women; 91 men)
4
Main findings
carotid artery diameter than men.
tory plaque phenotype compared with men. The highest
asymptomatic women.
RT tended to be higher than in those that did not use HRT.
was not statistically significant.
d wound closure were associated with perioperative
nfluence of female gender could not be analyzed properly while
ver the two involved countries.
young, male patients. Emboli during the intraoperative phase
tomatic patients.
e of complications after CEA was the increased thromboembolic
more than a two-fold increase in the number of emboli in the
lly significant.
le gender or 8 MES/hour with symptoms in the postoperative
is. Multivariate analysis revealed 8 MES/hour and a
associated with neurologic complications.
higher level of MES. This higher level of MES is associated with
of postoperative MES were identified: (1) female sex (P 
ative antiplatelet therapy (P  .37); and (3) patients having left-
ure was related to gender and type of closure.
ths after CEA revealed no significant gender difference in 95
nce existed between the ICA diameter of arteries that had
al carotid artery; MES, microembolic signals; TCD, transcranial Doppler.s24-3
aller
amma
nd in
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the i
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on in
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t.and asymptomatic stenosis (55 women; 125 men). Preop-
le; P,
l [CI],
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perioperative stroke rate among women on HRT (8.7%)
tended to be higher than among those without (1.2%; P
.08). Furthermore, in the postoperative period, there was
only one new stroke among patients not receiving HRT.
These data suggested that women on HRT are at increased
risk of stroke in the immediate postoperative period, with
Table II. Summary of methods of included articles24-34
Author Year Design
Pooled
analysis
CEA
patients Sy
Golledge et al24 1997 P x 192
Hellings et al25 2007 P x 450
Lane et al26 2003 R x 326
Ackerstaff et al27a 2000 R Nieuwegein 602
Seattle 456
Golledge et al28 2001 P x 235
Hayes et al29 2003 P x 775
Horn et al30 2005 R yes 991
Substudy:
Leicester 510
Amsterdam 185
Melbourne 139
Nieuwegein 126
Copenhagen 56
Sydney 50
Laman et al31 2002 P x 185
Stork et al32 2002 P x 141
Verhoeven et al33 2005 R x 319
Anderson et al34 1999 P x 126
CEA, Carotid endarterectomy; MES, microembolic signals; NA, not availab
aPooled analysis (odds ratio [OR] Nieuwegein 2.7, 95% confidence intervano further increase in risk over 5 years.26Thromboembolic potential
We identified seven articles that studied microembolic
potential in association with gender. Six studies28-33 found
a link between gender, MES, and outcome in various stages
of the procedure, although one27 did not.
Preoperative microembolic signals. Patients with
m Asymptomatic Antiplatelet therapy
0 NA
102 Aspirin (106 women, 249 men).
Oral anticoagulation (17 women, 48 men).
Statin (79 women,182 men).
5000 IU heparin before cross-clamping.
180 NA
NA Pre-op 100 mg aspirin daily.
Before cross clamping 5000 IU heparin.
NA Aspirin stop.
Before cross-clamping 5000 IU heparin.
NA Heparin 5000 IU before cross-clamping.
No intravenous Dextran or other
antiplatelets.
Post-op 75 mg aspirin.
NA Patient usual medication pre-op.
Systemic heparin 5000 IU.
Dextran when 25 emboli.
NA
NA Aspirin 75 mg daily, heparin 5000 EH,
Dextran when 25 emboli.
NA Oral anticoagulants stopped before
surgery, heparin 5000 IU, aspirin 500
mg when multiple MES during
monitoring 500 mg.
NA Aspirin, heparin, randomization for
Dextran.
NA Aspirin 100 mg daily, heparin 5000 IU,
Dextran.
NA Heparin 3500 IU, aspirin 100-150 mg
daily after discharge.
NA Heparin 5000 IU, aspirin 150 mg daily,
Dextran.
NA Oral anticoagulants stopped before
surgery.
Heparin 5000 IU.
Multiple MES during monitoring 500 mg
aspirin.
NA Aspirin week before surgery (76%).
Other platelet drugs before surgery (11%).
Not taken antiplatelet drugs (13%).
51% received Dextran started with
operation until -16 hours post-op.
49% placebo.
Heparin 5000-7000 IU.
67% protamine sulfate.
NA Pre-op antiplatelet therapy was continued.
Heparin 5000 IU before cross-clamping.
NA Aspirin continued to day of surgery.
Heparin 5000 IU.
prospective; Post-op, postoperative; Pre-op, preoperative; R, retrospective.
0.6-12.1 vs OR Seattle 0.4, 95% CI, 0.2-0.8).mpto
192
348
146
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NApreoperative transcranial Doppler (TCD) scan-detected
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emboli vs 22.1; P  .027).29 In another group of patients,
(146 men; 44 women) microembolization was detected
preoperatively in 15% (n  28).28 Of these, 26 were men
and only 2 were women with a median number of 2
emboli per hour (range, 1-31), meaning that preopera-
tive emboli were relatively more common in young, male
patients with echolucent plaques (RR 3.9; 95% CI, 1.0-
15.9).28 None of the other studies presented data on
preoperative embolization.
Intraoperative microembolic signals. Four studies
Table III. Plaque phenotype25
Plaque phenotype Women
All patients n  135
Atheromatous 29 (21.5%)
SMC (heavy) 51 (37.6%)
Macrophage staining (heavy) 18 (13.5%)
Collagen staining (heavy) 37 (27.6%)
Asymptomatic patients n  33
Atheromatous 3 (9%)
SMC (heavy) 17 (53%)
Collagen staining (high) 17 (53%)
Symptomatic patients n  102
Patients with TIA/stroke n  84
Atheromatous 23 (27%)
SMC (heavy) NA
Collagen staining (high) NA
Patients with amaurosis
fugaxa
n  18
CI, Confidence interval; NA, not available; RR, relative risk ratio; SMC, sm
Stable plaque: fibrous, high smooth muscle cell and collagen, low inflamm
individually add up to 100%.
aData not reported and not available for analysis.
Table IV. Plaque histology25
Plaque histology Women Men P valuec
All patients n  135 n  315
IL-6a 6.7 8.8 .2
IL-8a 25.9 51.3 .001
MMP-8a 4.2 7.1 .1
MMP-9a 1.6 2.6 .07
Asymptomatic patients n  33 n  69
IL-6a 6.3 7.9 .81
IL-8a 14.1 17.2 .18
MMP-8a 2.6 5.0 .18
MMP-9a 1.1 1.4 .19
Symptomatic patients n  102 n  246
Patients with TIA/stroke n  84 n  201
IL-6a 11.0 10.3 .56
IL-8a 41.9 83.3 .01
MMP-8a 5.7 9.2 .04
MMP-9a 1.7 2.9 .12
Patients with amaurosis
fugaxb
n  18 n  45
IL, Interleukin; MMP, matrix metalloproteinase.
aPg/mL.
bData not reported and not available for analysis.
cStatistically significant P  .05.described their outcomes of intraoperative emboli and gen-der.27,28,31,33 For clinical relevance, it is important to ana-
lyze if the occurrence of intraoperative MES has been
associated with procedural stroke. In a pooled analysis of
two studies, the investigators found that MES during
shunting and clamp release were not related to stroke.27
The authors pooled two analyses because there seemed to
be low complication rates in the analyses separately. On the
contrary, MES during wound closure (OR 2.3; 95% CI,
1.2-4.4) strongly predicted postoperative stroke in all pa-
tients even after adjusting for preoperative patient charac-
teristics (not gender) and TCD velocity variables.27 How-
ever, analysis for differences between men and women in
the preoperative phase could not be performed because the
female gender was heterogeneously distributed too much
between the two studies (Table II).
The relation of the number of embolic signals and the
development of early cerebrovascular complications was
investigated. In one study, no association was found be-
tween gender and the median embolic rate during dissec-
tion and wound closure.31 In two other studies, however,
such an association was indeed observed.28,33 One study
specified this to a statistically significant association be-
tween10MES during closure and perioperative outcome
in women.28 The other study documented a significant
relation between presence of emboli during wound closure,
the type of patching, and women.33 Adverse ischemic
events that occurred within 1 month postoperatively were
significantly associated with emboli during dissection.33
Postoperative microembolic signals. Five studies in-
vestigated the relation of postoperative emboli with gen-
der.27,29-32 In one study, the embolic rate during the
postoperative period was the best predictor of cerebrovas-
cular complications (CVC).31 This study suggested that
patients with an embolic rate of 0.9 emboli/minute or
more postoperatively had about a 60-fold risk of CVC (OR
Men RR 95% CI
n  315
127 (40.3%) 0.53 (0.38-0.76)
76 (24.2%) 1.57 (1.17-2.10)
66 (21.0%) 0.64 (0.39-1.03)
61 (19.4%) 1.42 (0.99-2.02)
n  69
27 (39%) 0.23 (0.08-0.71)
21 (30%) 1.69 (1.04-2.75)
15 (22%) 2.37 (1.36-4.14)
n  246
n  201
88 (44%) 0.63 (0.43-0.92)
40 (20%) NA NA
30 (15%) NA NA
n  45
muscle cell staining; TIA, transient ischemic attack.
cell content and decreased protease activity; Analysis of all characteristicsooth
atory65; 95% CI, 4-1128).31 During the postoperative period,
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median embolic rate than men (0.25 emboli/minute) and
a preponderance of women was found in the group with
CVC.31
Another study described that the number of postoper-
ative emboli did not differ between symptomatic and
asymptomatic persons, though it was related to gender.29
In this study, women’s risk of important postoperative
embolization was found to be 2.2 times higher than men
(95% CI, 1.2-3.9). Women more often had high levels of
postoperative emboli, defined as more than 25 emboli in
any 10 minute period during the first 3 postoperative hours
than men.29
A statistically significant association of female gender
and 8 MES an hour with postoperative adverse outcome
in univariate analysis was documented in a multicenter
study.30 Multivariate analysis revealed 8 MES an hour
(OR 8.1; 95% CI, 1.8-36.0) whereas female gender (OR
2.2; 95% CI, 0.9-5.5) showed a trend to be related with
neurologic complications.30 The relation between several
risk factors and the occurrence of postoperative MES iden-
tified three associated factors in another study: (1) female
gender (P  .027); (2) patients not receiving preoperative
antiplatelet therapy (P  .37); and (3) patients having
left-sided endarterectomy (P  .049).32 In the pooled
analysis of two studies, no significant relation between
gender and embolic potential after CEA was found.27
Restenosis
In our search strategy, we identified several articles
investigating restenosis rate after CEA, specifying this for
gender.15,34-55 A majority of these studies confirmed fe-
male gender as a risk factor for restenosis. Most studies
documented specifically about the technical aspect of this
finding by analyzing the type of closure, which is not the
focus of our review. Only one study reported about the
underlying cause for a possible association between gender
and the development of restenosis.34 Postoperative carotid
artery diameter was related to gender and compared be-
tween the restenosed and nonstenosed group of patients.
After 12 months, 11 of 38 women (29%) and 7 of 82 men
(9%) developed asymptomatic restenosis (RR 4; 95% CI,
1.4-8.1). Measurement of the ICA diameter in 95 patients
showed no significant gender difference in 65 men (4.7 
0.9) vs 30 women (4.7 0.7; mean difference 0.0; 95% CI,
0.4-0.4).34 In this study, no relationship between reste-
nosis, gender, and carotid artery diameter was found.
DISCUSSION
In our systematic analysis for etiological components
responsible for differential outcome between men and
women after CEA, we only found 11 relevant articles
meeting our inclusion criteria. These articles suggested
vessel diameter, plaque morphology, sex hormones, micro-
embolic potential, and restenosis to be gender-specific
characteristics influencing outcome after CEA. None of the
included studies discussed more than one of the factors
simultaneously.A recent editorial20 already emphasized the importance
of investigating the background of the existing gender
difference in CEA. With our systematic analysis, we tried to
provide an overview of the best available evidence. How-
ever, we must conclude that only a few studies investigated
patients with CEA with the focus on gender difference and
with analysis of the possibly related factors. Moreover,
these studies presented limited data and most conclusions
were speculative, because the studies were not designed to
answer this specific question. Moreover, the sizes of the 11
studies incorporated in our review varied from 126 to 991
patients. The smaller studies yielded less precise results as is
reflected in the width of the corresponding 95% CIs. Thus,
apart from a limited number of studies on the topic of our
review in the literature, the amount of information in some
of the studies found is also restricted.
We believe, in the results of our search strategy, that
plaque morphology and emboli were the best described
factors in demonstrating gender-related outcome differ-
ences in research with adequate study design.
In existing literature, different explanations are sug-
gested for the observed gender-based difference after CEA,
without providing any hard proof. We tried to find evi-
dence for these suggested arguments. First, several authors
mention the fact that the ICA vessel diameter of women is
smaller than that of men, resulting in a technically more
difficult approach in women.18,32 Indirect evidence on ICA
diameter influence has been provided by studies on the
benefit of standardized patching in women. Subsequently,
some authors assumed this smaller diameter to be the main
contributor to increased postoperative microembolization
and eventual operative site thrombosis. Surprisingly, to our
knowledge, a study that focused specifically on carotid
artery diameter, gender, and its direct relationship with
adverse postoperative neurologic outcome has never been
performed. The study we included tried to determine the
vessel diameter in relation with the development of residual
stenosis.24 Unfortunately, as far as we know, no further
follow-up of this patient cohort has been reported. Further-
more it must be kept in mind that this is a relatively small
study population with a limited follow-up. In previous
studies on operative factors influencing outcome, the ben-
efit of selective patching of the smaller carotid bifurcation
was proven, especially for women.14 Indirectly, this finding
implicated an association between smaller intraluminal ca-
rotid bifurcation and procedural outcome. However, as
already mentioned before, the smaller carotid diameter in
women as a cause of adverse outcome must be considered a
theoretical possibility while underlying gender-specific he-
modynamic evidence is lacking. Although there are articles
that have explored the relationship between gender and the
diameters of the common carotid artery (CCA) or the ICA,
it was not investigated whether women have worsened
outcome related to reduced arterial diameter.56
Second, plaque composition, and not merely degree of
stenosis, seems to be important in predicting adverse
events. It is striking that plaque characteristics are not only
related to presenting symptoms, but also predict events
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cially those without symptoms, showed to have more stable
plaques than men do according to Hellings et al.25 Asymp-
tomatic women had plaques containing less fat, less macro-
phages, more smooth muscle cells, lower levels of interleu-
kins, and lower levels of MMPs. This confirms that
asymptomatic women have more stable plaques than men.
The finding that women have more stable plaques than
men seems counterintuitive with the lower benefit from
CEA in women. However, on the contrary, this finding re-
emphasizes that not only plaque but also other gender-
related factors are responsible for the lower benefit from
revascularization. This means that treatment indicators in
womenmight have to be reconsidered and bemore restrictive
before considering surgical treatment in women. Therefore,
determination of plaque morphology could be of help in
predicting which patient might benefit from intervention and
which one would not. These findings, which will have to be
confirmed in further studies, could have clear implications
for adequate preoperative patient selection. If it could be
possible to differentiate between a vulnerable and a nonvul-
nerable plaque in the preoperative phase by (noninvasive)
imaging, one might be able to predict the relative benefit of
the operation being considered. It is likely that removal of
a stable plaque is less beneficial than removal of a vulnerable
plaque. However, it must be acknowledged that outcome is
not only dependent on plaque morphology, but also the
difference in coagulation factors as pronounced in embolic
potential may be contributing.
There is relatively well-documented evidence for a
higher embolic potential in women, especially in the post-
operative phase influencing the worsened outcome of
women after CEA.28,29,31,33 Not only after carotid artery
surgery do women have less benefit, this is also shown in
iliac array angioplasty and stenting and in coronary angio-
plasty.59,60 This might partly result from the fact that
women tend to have a higher thrombotic potential result-
ing in a higher rate of both intraoperative and postoperative
MES. This higher postoperative MES rate is independent
from the type of antiplatelet therapy being used.19 Clinical
consequences regarding the higher embolic potential in
women must be found in further development of optimal
intraoperative antiplatelet therapy (APT) to reduce intra-
operative and postoperative MES with the goal of postsur-
gical thrombotic prevention.
Only one study in our search strategy suggested a
worsened outcome by sex hormone influences.26 Unfortu-
nately, this study was performed in a retrospective fashion,
had a small sample size, and data, therefore, must be
considered merely suggestive. Moreover, confounding by
indication can influence outcome, still, confounding
factors were not specified. However, there is some contrib-
uting evidence because, in a previous report, a relation
between HRT and an increased rate of coronary and
thromboembolic events21 in women was shown. Besides,
more articles document about the relation of sex hormones
in developing atherosclerosis in the general population,still, the outcome seems variable.61-63 Therefore, further
research in this area is warranted.
In our opinion, restenosis after CEA is an important
factor to describe in an analysis on gender-related factors.
Women have a higher rate of restenosis than men. How-
ever, study of its causes is difficult and rarely performed.
Concerning cerebral outcome, ipsilateral adverse events are
not, per se, related to the development and degree of
restenosis.15,35,38,41 This suggests that restenosis in
women might be endogenous. One study determined the
relation between atherosclerotic plaque histology and the
occurrence of restenosis after CEA.64 Plaque composition
was an independent predictor of restenosis after CEA in
500 patients after 1 year of follow-up. Therefore, once
more, additional research about the role of plaque mor-
phology in developing restenosis in both men and women
is necessary.64,65
More articles have described risk factors for atheroscle-
rosis in general, which can be related to carotid artery
stenosis, without investigating CEA66-73 (Appendix and Ta-
ble, online only). Other investigated factors suggesting asso-
ciationwithworsenedoutcome inwomen are for example: (1)
hemodynamic status,74 (2) general risk factors for stroke,75,76
and (3) heightened sensitivity to antiplatelet regimens.77 Un-
fortunately, these topics were investigated in a healthy patient
population or a population not undergoing CEA. Conse-
quently, a direct relation with perioperative complications
from CEA could not be drawn from these studies and,
therefore, remains unclear. Patients with shorter height are
an example of a considered high-risk population (as a
surrogate for smaller artery size), but the authors did not
specify this for gender.78 Moreover, female gender was
found to be an independent predictor of perioperative
mortality after coronary artery bypass grafting even after
accounting for all comorbidities.79 These findings suggest
that worsened outcome might be contributable specifically
to gender. Unfortunately, also these authors were not able
to determine the exact underlying gender-related cause.
Study limitations. Our systematic review addresses a
difficult research question, because studies had to confirm a
gender difference in CEA outcome and also discuss a factor
being responsible for this. To achieve the optimal selection
of articles on this specific topic, we used a very broad search
strategy so we would not miss any relevant articles. How-
ever, by performing the selection of articles based on our
inclusion and exclusion criteria, we only focused on pa-
tients undergoing CEA. We chose a descriptive manner of
results presentation because it was impossible quantitatively
to pool findings. As a result, the review clearly shows the
lack of knowledge on gender-related influences on the
procedural outcome of CEA. Nevertheless, by focusing
only on patients undergoing CEA, as a consequence, arti-
cles investigating other possible explanations or risk factors
in healthy patients for the existing gender difference were
excluded.
Future perspectives. The characteristics we assumed
to be valuable should be indicators for new research on the
relation of gender and outcome after CEA. The proven lack
JOURNAL OF VASCULAR SURGERY
Volume 52, Number 4 den Hartog et al 1069of the literature on this subject may encourage investigators
to performmore studies focusing on specific factors causing
the outcome differences between men and women after
CEA.
CONCLUSION
Higher embolic potential in women and relatively sta-
ble female plaque morphology are the best described fac-
tors influencing the difference in outcome between men
and women after CEA. However, the overall evidence for
outcome differences by gender-specific characteristics in
the literature is limited. Better understanding of the etiol-
ogy of gender-related mechanisms might result in reduc-
tion of postoperative stroke risk for all patients by improv-
ing patient selection for CEA.
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Causes Author Year CEA Who What Main conclusions
Influence of sex
hormones
Vikan 2009 No Cohort of men Testosterone No prospective associations between sex
hormone levels and change in plaque
area or IMT.
Wildman 2008 No Middle-aged women Menopausal transition
declining estrogen
levels
The menopausal transition and declining
estrogen levels are associated with
alterations of the peripheral
vasculature, which may help to explain
the increased risk of cardiovascular
disease with postmenopause.
Marfella 2008 No Asymptomatic
postmenopausal
women
HRT HRT inhibits plaque ubiquitin-
proteasome activity by decreasing
oxidative stress generation in
postmenopausal women.
Debing 2008 Yes Male CEA patients Androgen Positive association between low serum
androgen levels and severe ICA
atherosclerosis in men.
Karim 2008 No Postmenopausal
women
Estrogen & SHBG Estrogen and SHBG are associated with
reduced subclinical atherosclerosis
progression in healthy
postmenopausal women.
Montalcini 2007 No Postmenopausal
women
Androgens Suggest a possible protective role of
endogenous androgens at least on
carotid atherosclerosis.
Montalcini 2007 No Postmenopausal
women
Obesity metabolic
syndrome
The metabolic syndrome but not obesity
is associated to carotid atherosclerosis
in postmenopausal women.
Debing 2007 Yes Postmenopausal
women
with/without
atherosclerosis
Androgen Levels of androgens in postmenopausal
women have a protective role in the
development of atherosclerosis of
ICA.
Muller 2004 No Aging men Endogenous sex
hormones
Low free testosterone levels were related
to IMT of the common carotid artery
in elderly men independently of
cardiovascular risk factors.
Hsia 2004 No Healthy women Estrogen & progestin
peripheral arterial
disease
Among generally healthy
postmenopausal women, conjugated
estrogens with progestin did not
confer protection against peripheral
arterial disease.
Iemolo 2004 No Patients with
artherosclerosis
Carotid stenosisplaque
area
Women have more stenosis but less
plaque than men, suggesting that
differences in sex hormones may affect
remodeling of atherosclerosis. Plaque
area was a stronger predictor of
outcomes than was stenosis.
Le Gal 2003 No Postmenopausal HRT carotid plaque/
IMT
These data suggest that HRT use may
prevent the development of
atherosclerotic plaques in
postmenopausal women, especially
when estrogens are administered by
transdermal route.
Golden 2002 No Postmenopausal
with and without
CAS
Testosterone SHBG Higher total testosterone and SHBG to
be inversely related to carotid
atherosclerosis, suggesting their
potential importance in reducing
atherosclerotic risk in postmenopausal
women not using HRT.
Angerer 2001 No Postmenopausal HRT 1 year of HRT was not effective in
slowing progression of subclinical
atherosclerosis in postmenopausal
women at increased risk.
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Causes Author Year CEA Who What Main conclusions
Joakimsen 1999 No Men and women
25-84 yrs
Prevalence plaque
morphology
The sex difference in the prevalence of
atherosclerosis and the female age
trend in atherosclerosis show
significant changes at the age of
approximately 50 years, suggesting an
adverse effect of menopause on
atherosclerosis.
Bernini 1999 No Pre- &
postmenopausal
women
Sex hormones IMT DHEA-S and androgens in women are
correlated with lower risk of carotid
artery atherosclerosis.
Griewing 1999 No Postmenopausal
women
with/without
HRT
HRT Women receiving HRT develop less
severe carotid atherosclerosis, an effect
which may be mediated by direct
hormonal effects on the carotid wall
and, in part, by the indirect influence
of hormones on lipoproteins. HRT
may, indeed, be more effective on
existing atherosclerotic plaques.
Sutton-
Tyrell
1998 No Pre &
postmenopausal
women
Prevalence carotid plaque
IMT several risk factors
Risk factors measured before menopause
are clearly associated with subclinical
disease measured both concurrently
and at 5 to 8 years after menopause.
Lassila 1997 No Healthy women Several possible RF Premenopausal values of triglycerides,
pulse pressure, and ever smoking were
independently related to average IMT
after we controlled for age and years
after menopause.
Hemodynamic
factors
Comerota 2004 No Database carotid
arteriogram
Carotid blood flow
velocity
Women have higher carotid blood flow
velocity than men. Gender differences
exist and are notably different at
clinically relevant thresholds for
intervention.
Schulz 2001 No Vessels with and
without CAS
Carotid bifurcation
anatomy
Sex differences in carotid bifurcation
anatomy are not limited to absolute
vessel size. In addition, the outflow to
inflow area ratio is bigger in women,
and relative to the CCA and ECA,
women have larger ICAs than men.
Macchi 1993 No Carotid artery
healthy & diseased
Original arterial calibers
Doppler flow velocity
The correlation between the degree of
stenosis and the gravity of the
symptomatology, and the occurrence
of cerebrovascular events, was
observed to increase significantly when
the residual luminal area (of the
stenotic artery) was less than 2.5 mm.
This relationship tended to hold more
for men than for women; however,
the difference was not statistically
significant.
Montalcini 2008 No Patients
with/without
carotid
atherosclerosis
Brachial artery diameter Brachial artery diameter could help to
identify subjects at high cardiovascular
risk, at least in postmenopausal
women.
Risk factors for
stroke
Loizou 2009 No Asymptomatic
subjects at risk for
atherosclerosis
Composition/texture of
media layer
Findings suggest that ultrasound image
texture analysis of the media layer has
potential as an assessment biomarker
for the risk of stroke.
Wittrup 2000 No Patients with carotid
stenosis or
nonfatal ICVD
Asn291Ser These results suggest that the Asn291Ser
substitution in lipoprotein lipase is not
associated with nonfatal increased risk
of cerebrovascular disease in men but
that it possibly confers a 2-fold risk in
women.
Davis 1994 No Women with stroke Outcome after stroke Women may be more sensitive to
warfarin than men.
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Risk factors for
cardiovascular
disease
Canter 2009 No Female veterans Prevalence PAD
atherosclerotic risk
factors
Show a high prevalence of CVD risk
factors and low knowledge levels
among ambulatory veteran women.
Continued efforts to educate women
and providers about CVD risk factors,
heart-healthy behaviors, screening,
and treatment are vital to improve the
current state of women’s health and
decrease future adverse cardiac event
rates.
de Weert 2009 No Pts with ischemic
cerebrovascular
disease
Calcification vs
cardiovascular disease
Calcifications were associated with
higher age and male gender. The
presence and volume of calcifications
were independently associated with
cardiovascular risk factors.
Hughes 2008 No Patients admitted for
coronary
angiography
Brachial FMD IMT Brachial FMD, rather than carotid IMT,
was an independent predictor for
cardiovascular events after adjusting
for the extent of CAD. Impaired
brachial endothelial function in
women without significant CAD was
associated with an increased risk of
spontaneous cardiovascular events.
Hughes 2007 No European and South
Asian adult men
with/without
coronary disease
Circulating EPCs Reduction in EPC numbers may be an
independent risk factor for
atherosclerosis but does not explain
ethnic differences in cardiovascular
risk.
Spence 2004 No Patients with
atherosclerosis
Total plaque area risk
factors
Total carotid plaque area and carotid
stenosis had different associations with
specific atherosclerosis risk factors. For
future studies of the determinants of
atherosclerosis, it is important to
distinguish between different
phenotypes and to appreciate that
they will not necessarily have the same
determinants.
Risk factors for
atherosclerosis
Skilton 2009 No Cohort of women &
men with at least
1 risk factor
Parity These findings indicate that
childbearing, but not child-rearing,
may be a risk factor for atherosclerosis,
and suggest the potential importance
of considering the number of children
when assessing the level of
cardiovascular risk in women.
Haukkamaa 2009 No Women with a
history of pre-
eclampsia
Pre-eclampsia Suggest that pre-eclampsia is an
independent risk factor as regards
developing plaque later in life.
Halvorsen 2009 No Individuals
examined with
ultrasonography
Inflammatory markers/
plaque
Sex-dependent differences in associations
between measures of carotid
atherosclerosis and inflammatory
markers. CRP did not discriminate
echolucent from echogenic carotid
plaques in either gender.
Fan 2007 No Women and men
40-60 yrs
HDL-C IMT HDL-C was protective against
progression of carotid atherosclerosis
in middle-aged men, anti-atherogenic
effects of HDL may diminish in
women around the age of menopause.
Sander 2007 No Men and women CRP The association between hsCRP and
progression of early carotid
atherosclerosis shows sex differences.
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Kawamoto 2007 No Healthy men and
women
Metabolic syndrome The effect of MetS in early carotid
atherosclerosis is more pronounced in
women than in men, and the impact
of MetS components on carotid IMT
differs between men and women.
Svartberg 2006 No Men Testosterone IMT Inverse association between total
testosterone levels and IMT of the
carotid artery in men that was present
also after excluding men with CVD,
but was not independent of BMI.
Lo 2006 No Healthy women Obesity, body
composition,
adinopectine
Obesity is associated with increased
common carotid IMT in young and
middle-aged women. Adiponectin and
abdominal adiposity are associated
with carotid IMT in this population.
Desvarieux 2004 No Patients with clinical
periodontal
examination
Tooth loss peridontitis Our data suggest that tooth loss and
long-term periodontitis are related to
subclinical atherosclerosis in men but
not women.
Kofoed 2002 No Patients with carotid
artery stenosis
Triglyceride vs rupture
prone plaques
By comparison, female cases with carotid
stenosis or50% had higher fasting
and postprandial triglyceride levels
than did controls.
Kawamoto 2002 No BMI 22 Abdominal wall fat Abd wall fat index was a significant
independent contributing factor along
with known risk factors such as age,
systolic blood pressure, total-
cholesterol, and HDL-cholesterol.
AFI was useful in evaluating disorders
of metabolism, circulation, and
atherosclerosis.
Rubba 2001 No Healthy middle aged
women
Atherosclerotic lesion vs
cardiovascular risk
factors
In a cohort of clinically healthy, middle-
aged women, we found a site-specific
association of traditional risk factors
and oxidation markers with early
atherosclerotic lesions in arterial
segments differing in geometry, shear
stress, extracellular matrix
composition, and cell type
populations.
Stensland-
Brugge
2001 No Men and women
25-84 yrs
Several possible RF Whereas triglyceride levels were
associated with IMT independently of
HDL cholesterol in women only,
Stensland-
Brugge
2000 No Middle aged men
and women
Several possible RF Established cardiovascular risk factors are
independent predictors of subclinical
atherosclerosis measured after 15 years
of follow-up. There may be significant
sex differences in the relationship
between triglycerides, smoking, and
physical activity and the risk of
atherosclerosis.
House 1999 No Patients with
peripheral arterial
disease
Prevalence of
asymptomatic carotid
artery stenosis
Females with abdominal aortic
aneurysms had a greater prevalence of
carotid stenosis.
Wityk 1996 No Pts with stroke/TIA Influence of sex on
location of
atherosclerosis in
The distribution of cerebral
atherosclerosis is influenced by race
and sex but not by other vascular riskcerebral vessels factors.
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Defined high
risk groups for
CEA
Dorigo 2009 Yes CEA patients Compare early/late
results risk factors
Female sex per se does not represent an
adjunctive risk factor during CEA,
with early and long term results
comparable to those obtained in male
patients. Found subgroups of female
patients at higher surgical risk,
requiring careful intra- and
postoperative management.
Kang 2009 Yes CEA patients Specific variables Anatomic and technical features are the
important predictors of perioperative
stroke, whereas critical limb ischemia
and poor functional status are
important predictors of death for
patients undergoing CEA.
BMI, Body mass index; CAD, coronary artery disease; CAS, carotid artery stenting; CCA, common carotid artery; CEA, carotid endarterectomy; CRP,
C-reactive protein; CVD, cerebral vascular disease; DHEA-S, serum dehydroepiandrosterone sulfate; EPC, endothelial progenitor cells; FMD, flow-mediated
vasodilation;HDL-C, high-density lipoprotein cholesterol;HRT, hormone replacement therapy; ICA, internal carotid artery; ICVD, ischemic cerebrovascular
disease; IMT, intima-media thickness;MetS,metabolic syndrome; PAD, peripheral arterial disease;RF, radiofrequency; SHBG, Sex hormone-binding globulin;
TIA, transient ischemic attack.
